299 related articles for article (PubMed ID: 27043884)
21. [Validation of the IBS-SSS].
Betz C; Mannsdörfer K; Bischoff SC
Z Gastroenterol; 2013 Oct; 51(10):1171-6. PubMed ID: 24122378
[TBL] [Abstract][Full Text] [Related]
22. Irritable bowel syndrome is significantly associated with somatisation in 840 patients, which may drive bloating.
Patel P; Bercik P; Morgan DG; Bolino C; Pintos-Sanchez MI; Moayyedi P; Ford AC
Aliment Pharmacol Ther; 2015 Mar; 41(5):449-58. PubMed ID: 25586008
[TBL] [Abstract][Full Text] [Related]
23. Fecal incontinence in irritable bowel syndrome: Prevalence and associated factors in Swedish and American patients.
Simrén M; Palsson OS; Heymen S; Bajor A; Törnblom H; Whitehead WE
Neurogastroenterol Motil; 2017 Feb; 29(2):. PubMed ID: 27581702
[TBL] [Abstract][Full Text] [Related]
24. Prevalence of irritable bowel syndrome in Korea: population-based survey using the Rome II criteria.
Han SH; Lee OY; Bae SC; Lee SH; Chang YK; Yang SY; Yoon BC; Choi HS; Hahm JS; Lee MH; Lee DH; Kim TH
J Gastroenterol Hepatol; 2006 Nov; 21(11):1687-92. PubMed ID: 16984590
[TBL] [Abstract][Full Text] [Related]
25. Rome III survey of irritable bowel syndrome among ethnic Malays.
Lee YY; Waid A; Tan HJ; Chua AS; Whitehead WE
World J Gastroenterol; 2012 Nov; 18(44):6475-80; discussion p. 6479. PubMed ID: 23197894
[TBL] [Abstract][Full Text] [Related]
26. [A comparison between Rome III and Rome II criteria in diagnosing irritable bowel syndrome].
Wang AJ; Liao XH; Hu PJ; Liu SC; Xiong LS; Chen MH
Zhonghua Nei Ke Za Zhi; 2007 Aug; 46(8):644-7. PubMed ID: 17967234
[TBL] [Abstract][Full Text] [Related]
27. The Prevalence of Constipation and Irritable Bowel Syndrome in Parkinson's Disease Patients According to Rome III Diagnostic Criteria.
Mishima T; Fukae J; Fujioka S; Inoue K; Tsuboi Y
J Parkinsons Dis; 2017; 7(2):353-357. PubMed ID: 28157108
[TBL] [Abstract][Full Text] [Related]
28. Intestinal symptoms and psychological factors jointly affect quality of life of patients with irritable bowel syndrome with diarrhea.
Zhu L; Huang D; Shi L; Liang L; Xu T; Chang M; Chen W; Wu D; Zhang F; Fang X
Health Qual Life Outcomes; 2015 Apr; 13():49. PubMed ID: 25925746
[TBL] [Abstract][Full Text] [Related]
29. A randomly selected population sample undergoing colonoscopy: prevalence of the irritable bowel syndrome and the impact of selection factors.
Kjellström L; Molinder H; Agréus L; Nyhlin H; Talley NJ; Andreasson A
Eur J Gastroenterol Hepatol; 2014 Mar; 26(3):268-75. PubMed ID: 24384686
[TBL] [Abstract][Full Text] [Related]
30. Psychosocial distress and somatic symptoms in community subjects with irritable bowel syndrome: a psychological component is the rule.
Choung RS; Locke GR; Zinsmeister AR; Schleck CD; Talley NJ
Am J Gastroenterol; 2009 Jul; 104(7):1772-9. PubMed ID: 19491833
[TBL] [Abstract][Full Text] [Related]
31. [Prevalence of irritable bowel syndrome and associated factors according to the Rome III diagnostic criteria in a general population in Colombia].
Gómez Alvarez DF; Morales Vargas JG; Rojas Medina LM; Mújica Oviedo SC; Camacho López PA; Rueda Jaimes GE
Gastroenterol Hepatol; 2009; 32(6):395-400. PubMed ID: 19520461
[TBL] [Abstract][Full Text] [Related]
32. Prevalence of irritable bowel syndrome in the French population according to the Rome I criteria.
Bommelaer G; Dorval E; Denis P; Czernichow P; Frexinos J; Pelc A; Slama A; El Hasnaoui A
Gastroenterol Clin Biol; 2002 Dec; 26(12):1118-23. PubMed ID: 12520200
[TBL] [Abstract][Full Text] [Related]
33. Overlap of symptoms of gastroesophageal reflux disease, dyspepsia and irritable bowel syndrome in the general population.
Rasmussen S; Jensen TH; Henriksen SL; Haastrup PF; Larsen PV; Søndergaard J; Jarbøl DE
Scand J Gastroenterol; 2015 Feb; 50(2):162-9. PubMed ID: 25525975
[TBL] [Abstract][Full Text] [Related]
34. Prevalence of irritable bowel syndrome in caregivers of patients with chronic diseases.
Remes-Troche JM; Torres-Aguilera M; Montes-Martínez V; Jiménez-García VA; Roesch-Dietlen F
Neurogastroenterol Motil; 2015 Jun; 27(6):824-31. PubMed ID: 25817438
[TBL] [Abstract][Full Text] [Related]
35. Comorbidity and use of health-care services among irritable bowel syndrome sufferers.
Hillilä MT; Siivola MT; Färkkilä MA
Scand J Gastroenterol; 2007 Jul; 42(7):799-806. PubMed ID: 17558902
[TBL] [Abstract][Full Text] [Related]
36. Subtyping the irritable bowel syndrome by predominant bowel habit: Rome II versus Rome III.
Ersryd A; Posserud I; Abrahamsson H; Simrén M
Aliment Pharmacol Ther; 2007 Sep; 26(6):953-61. PubMed ID: 17767480
[TBL] [Abstract][Full Text] [Related]
37. The epidemiology of irritable bowel syndrome: Symptom development over a 3-year period in Denmark. A prospective, population-based cohort study.
Krogsgaard LR; Engsbro AL; Jones MP; Bytzer P
Neurogastroenterol Motil; 2017 Apr; 29(4):. PubMed ID: 27865035
[TBL] [Abstract][Full Text] [Related]
38. Subtypes of irritable bowel syndrome on Rome III criteria: a multicenter study.
Yao X; Yang YS; Cui LH; Zhao KB; Zhang ZH; Peng LH; Guo X; Sun G; Shang J; Wang WF; Feng J; Huang Q
J Gastroenterol Hepatol; 2012 Apr; 27(4):760-5. PubMed ID: 21929652
[TBL] [Abstract][Full Text] [Related]
39. Prevalence, comorbidity and impact of irritable bowel syndrome in Norway.
Vandvik PO; Lydersen S; Farup PG
Scand J Gastroenterol; 2006 Jun; 41(6):650-6. PubMed ID: 16716962
[TBL] [Abstract][Full Text] [Related]
40. Does frequency of restless legs syndrome and poor sleep quality increase with age in irritable bowel syndrome?
Acay A; Bal A; Oruc S; Ozkececi T; Sariaydin M; Demirbas H; Acarturk G
Wien Klin Wochenschr; 2016 Dec; 128(Suppl 8):604-609. PubMed ID: 27624325
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
